Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
eLum Technologies
AddedFeb 15, 2024
UpdatedJun 18, 2026
eLum Technologies

eLum Technologies

Seed

ELum Technologies: Innovating endovascular disease solutions through disruptive medical devices.

HQ
Fremont, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees

ELum Technologies is an early-stage medical device company dedicated to innovating solutions for endovascular diseases. Their mission is to develop disruptive technologies that significantly improve patient outcomes. The company focuses on creating advanced medical devices designed to address complex vascular conditions.

ELum Technologies has made notable strides in the medical device industry, contributing to advancements in endovascular treatment. Their innovative approach has garnered attention and support from key stakeholders in the healthcare sector.

eLum Technologies - Similar Companies

Elm Tree Medical logo

Elm Tree Medical

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Emboline logo

Emboline

Traverse Vascular logo

Traverse Vascular

East End Medical logo

East End Medical

Lumenxt logo

Lumenxt

lumenxt.com

Efemoral Medical logo

Efemoral Medical

Elutia logo

Elutia

elutia.com

Transluminal Technologies logo

Transluminal Technologies

transluminal.net

OnLume logo

OnLume

onlume.com

Elixir Medical logo

Elixir Medical

elixirmedical.com

LMT logo

LMT

lmtech.io

BioInspire Technologies logo

BioInspire Technologies

Nanovasc logo

Nanovasc

nanovasc.com

Penumbra logo

Penumbra

penumbrainc.com

eLum Technologies - Quick Facts

Who are eLum Technologies' competitors?

Companies similar to eLum Technologies include Elm Tree Medical, Advanced Medical Device Technologies, Emboline and Traverse Vascular.

When was eLum Technologies founded?

eLum Technologies was founded in 2015.

Where is eLum Technologies' headquarters located?

eLum Technologies' headquarters is located in Fremont, CA, US.

When was eLum Technologies' last funding round?

eLum Technologies' most recent funding round was for $2M (USD) in April 2020.

How much has eLum Technologies raised to-date?

As of Apr 15, 2020, eLum Technologies has raised a total of $8.1M (USD).

How many employees does eLum Technologies have?

eLum Technologies has 30 employees as of Feb 5, 2024.

eLum Technologies - Classification

Ownership
  • Private
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified